RECENT NEWS

Thousands of patients in Stockton-on-Tees are set to benefit from quicker access to tests, checks and scans, with a new community diagnostic centre set to open later this year.

The Government has pledged an additional £10 million to provide 29 new NHS breast cancer screening units and nearly 70 life-saving upgrades to services in areas where they are most needed, in a bid to speed up cancer diagnosis.

Patients hospitalised with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, has found that inexpensive over-the-counter aspirin is just as effective.

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British Heart Foundation (BHF) Data Science Centre at Health Data Research UK.

The AfPP Board of Trustees have announced that Dawn Stott has made the decision to retire. Dawn will be stepping down from her position as AfPP CEO at the end of May 2023.

The brand new ‘UK Healthcare Pavilion’ magazine, showcasing the best of UK HealthTech, and comprising a dedicated UK show guide for this year’s Arab Health trade fair, is now available.

The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.

New guidance has been published to enable clinicians to design and maintain safe systems that will reduce the risk and potential impact of human error.

Thousands of extra medically fit patients will be discharged from hospitals into community care settings, such as care homes, over the coming weeks to free up hospital beds and reduce pressure on the NHS, the Health and Social Care Secretary, Steve Barclay, has announced.

​Researchers from Sheffield Teaching Hospitals have found that an at-home test which uses saliva rather than blood provides a faster and more convenient way to diagnose adrenal insufficiency.

Independent research organisation MindMetre Research has published the findings of an enquiry on the use of passive safety-engineered devices among NHS Trusts. The enquiry sought to determine whether the use of passive devices may be linked to mis-dosage or non-delivery of insulin. The study found a third of NHS Trusts had experienced instances of mis-dosage or non-delivery of insulin to patients when passive devices were being used.

The UK government is almost a decade behind achieving its target for England to be smoke-free by 2030, a new report published by Cancer Research UK reveals.

Latest data from the UK Health Security Agency (UKHSA) continues to show scarlet fever and group A strep (GAS) infections remain high.

The public will have faster access to life-saving defibrillators as the Government has announced a new £1 million fund to increase the number of automated external defibrillators (AEDs) in communities most in need, providing an estimated 1,000 new defibrillators in community spaces across England.

As the COVID-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them. However, Yale researchers have found that testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses not identified in standard tests.

Long-term owner and guardian of the Harley Street Medical Area (HSMA), The Howard de Walden Estate is returning to Arab Health for the sixth year, bringing with it 12 of the HSMA’s world leading clinics and hospital groups.

Carol Kefford, former Clinical Director and Chief Nurse at Nuffield Health, and current Chief Nursing Executive at HCA Healthcare UK, has been awarded an OBE for services to nursing in The King’s New Year Honours List 2023.

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for future cancer treatments.

Moderna is to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre.

People with Lynch syndrome have a higher hereditary risk of colon cancer. Despite regular endoscopic surveillance, it remains elevated in those affected. Researchers at the National Center for Hereditary Tumor Diseases (NZET) at Bonn University Hospital (UKB) have now found that artificial intelligence (AI) can improve the effectiveness of colonoscopy in the presence of Lynch syndrome. The study results have been published online in the United European Gastroenterology Journal.